Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: A single center analysis and review of the literature [8]

Leukemia and Lymphoma

Volumn 48, Issue 11, 2007, Pages 2255-2260

  Strobel, Eva Susanne ^a,b   Bauchmüller, Kris ^a   Ihorst, Gabriele ^c   Engelhardt, Monika ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b St Georg Vorsorge und Rehabilitationskliniken   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BLEOMYCIN; CHAMOMILE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; HEMOPOIETIC GROWTH FACTOR; MELPHALAN; OPIATE; PREDNISONE; PROCARBAZINE; THYMOL; VINBLASTINE; VINCRISTINE;

ADULT; ANTIBIOTIC THERAPY; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BEAM THERAPY; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HODGKIN DISEASE; HUMAN; LETTER; MALE; MOUTH HYGIENE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STOMATITIS; SURVIVAL RATE; TOOTH BRUSHING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CYTARABINE; FEMALE; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MELPHALAN; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PODOPHYLLOTOXIN; PROGNOSIS; RISK FACTORS; STOMATITIS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 36048992526     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701636492     Document Type: Letter

References (20)

1. Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D. and Kewalramani, T. (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med, 351, pp. 2590-2598.
2. Bolwell, B. J., Kalaycio, M., Sobecks, R., Andresen, S., Kuczkowski, E. and Bernhard, L. (2002) A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation. Bone Marrow Transplantat, 30, pp. 587-591.
3. Blijlevens, N. and Sonis, S. (2007) Palifermin (recombinant keratinocyte growth factor-1): A pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis. Ann Oncol, 18, pp. 817-826.
4. Fanning, S. R., Rybicki, L., Kalaycio, M., Andresen, S., Kuczkowski, E. and Pohlmann, B. (2006) Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies. Br J Haematol, 135, pp. 374-381.
5. Milpied, N., Deconinck, E., Gaillard, F., Delwail, V., Foussard, C. and Berthou, C. (2004) Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med, 350, pp. 1287-1295.
6. Zeiser, R., Deschler, B., Bertz, H., Finke, J. and Engelhardt, M. (2004) Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome. Bone Marrow Transplant, 34, pp. 1057-1065.
7. Haas, P. S., Bauchmüller, K., Kühnemund, A., Finke, J., Ihorst, G. and Engelhardt, M. (2006) Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: A single-center analysis over a 12-year period. Ann Hematol, 85, pp. 191-193.
8. Denz, U., Haas, P., Wäsch, R., Einsele, H. and Engelhardt, M. (2006) State of the art therapy in multiple myeloma and future perspectives. Eur J Cancer, 42, pp. 1591-1600.
9. Engelhardt, M., Zeiser, R., Ihorst, G., Finke, J. and Müller, C. I. (2006) High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma. J Cancer Res Clin Oncol, 133, pp. 1-11.
10. Müller, A MS, Ihorst, G., Waller, C. F., Dölken, G., Finke, J. and Engelhardt, M. (2006) Intensive chemotherapy with autologous peripheral blood stem cell transplantation during a 10-year period in 64 patients with germ cell tumor. Biol Blood Marrow Transplant, 12, pp. 355-365.
11. Arfons, L. M. and Lazarus, H. M. (2005) Total parental nutrition and hematopoietic stem cell ransplantation: An expensive placebo?. Bone Marrow Transplant, 36, pp. 281-288.
12. Josting, A., Rudolph, C., Mapara, M., Glossmann, J. P., Sienawski, M. and Sieber, M. (2005) Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: Results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG). Ann Oncol, 16, pp. 116-123.
13. Wardley, A. M., Jayson, G. C., Swindell, R., Morgenstern, G. R., Chang, J. and Bloor, R. (2000) Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol, 110, pp. 292-299.
14. Josting, A., Sieniawski, M., Glossmann, J. P., Staak, O., Nogova, L. and Peters, N. (2005) High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: Results of a multicenter phase II study. Ann Oncol, 16, pp. 1359-1365.
15. Jantunen, E., Kuittinen, T. and Nousiainen, T. (2003) BEAC or BEAM for high-dose therapy in patients with Non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy. Leuk Lymphoma, 44, pp. 1151-1158.
16. Glossmann, J. P., Staak, J. O., Nogova, L., Diehl, V., Scheid, C. and Kisro, J. (2005) Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma. Ann Hematol, 84, pp. 517-525.
17. Martin, A., Caballero, M. D., Pérez-Simón, J. A., López-Holgado, N., Mateos, M. V. and Canizo, M. C. (2004) Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: A single-centre sequential-cohort study. Bone Marrow Transplant, 34, pp. 675-682.
18. Holowiecki, J., Giebel, S., Wojnar, J., Krawczyk-Kulis, M., Stella-Holowiecka, B. and Kachel, L. (2002) Autologous hematopoietic stem cell transplantation for high-risk Hodgkin's disease: A single-center experience with the first 100 patients. Transplantation Proc, 34, pp. 3378-3383.
19. Argiris, A., Seropian, S. and Cooper, D. L. (2000) High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease. Ann Oncol, 11, pp. 665-672.
20. Mills, W., Strang, J., Goldstone, A. H. and Linch, D. C. (1995) Dose intensification of etoposide in the BEAM ABMT protocol for malignant lymphoma. Leuk Lymphoma, 17, pp. 263-270.